CJC-1295 Ipamorelin research peptide / Ipamorelin Research Peptide Blend

Description

CJC-1295 (No DAC) / Ipamorelin Research Peptide Blend

 

CJC-1295 Ipamorelin research peptide/ Ipamorelin is a defined research peptide blend containing two synthetic peptides: CJC-1295 without the DAC modification and Ipamorelin.

The two components have distinct molecular structures and are commonly investigated within research models involving peptide-receptor interactions and signaling pathways. For laboratory applications, the combination provides researchers with a defined peptide system suitable for analytical, biochemical and structure-function investigations.

CJC-1295 Ipamorelin research peptide is also commonly described as modified GRF 1-29, while Ipamorelin is a synthetic pentapeptide associated with the growth hormone secretagogue receptor system.

The product should be evaluated according to its actual LV Longevity Peptides specifications and batch-specific Certificate of Analysis (COA).

---

What Is CJC-1295 / Ipamorelin?

The product consists of two individually characterized peptides:

CJC-1295 Ipamorelin research peptide

CJC-1295 without DAC is a synthetic peptide corresponding to a modified GHRH-related sequence. It is commonly referred to as CJC-1295 No DAC or modified GRF 1-29.

Ipamorelin

Ipamorelin is a synthetic pentapeptide belonging to the growth hormone secretagogue class. Its defined structure makes it useful for laboratory investigations involving peptide-receptor interactions and biochemical signaling models.

Combining the two compounds creates a two-component research peptide system that can be evaluated under controlled laboratory conditions.

---

CJC-1295 / Ipamorelin Chemical Information

The CJC-1295 Ipamorelin research peptide and Ipamorelin chemical information above corresponds to the product composition identified on the supplied product reference.

Important: The exact formulation, blend ratio, quantity and analytical specifications for the LV product should be taken from the current LV batch documentation.

---

CJC-1295 / Ipamorelin Research Applications

Peptide Structure and Sequence Research

The two defined peptide components can be evaluated individually and collectively in laboratory studies examining:

• Peptide structure
• Amino-acid sequence characteristics
• Molecular identity
• Peptide interactions
• Structure-function relationships

Receptor Interaction Research

CJC-1295 and Ipamorelin represent two distinct peptide signaling systems. This makes the combination relevant to controlled research investigating different peptide-receptor interactions and signaling mechanisms.

Biochemical Research

The blend can be evaluated in controlled biochemical systems to examine peptide behavior, molecular interactions and assay responses.

Stability and Degradation Studies

Researchers can investigate the stability characteristics of the combined peptide system under defined laboratory conditions.

Potential analytical areas include:

• Peptide degradation
• Stability profiling
• Chromatographic behavior
• Molecular characterization
• Component-specific analysis

Analytical Peptide Research

CJC-1295/Ipamorelin can be characterized using appropriate analytical techniques such as:

• HPLC
• LC-MS
• Mass spectrometry
• Peptide identity testing
• Purity analysis

The exact analytical method should be selected according to the research objective and laboratory protocol.

---

Certificate of Analysis (COA)

A batch-specific Certificate of Analysis is an important resource for researchers evaluating CJC-1295/Ipamorelin material.

Where available, the LV COA should provide information such as:

• Product identification
• Batch or lot number
• Component identification
• Purity/assay results
• Analytical testing method
• Testing date
• Applicable laboratory information

Why Use CJC-1295 / Ipamorelin for Laboratory Research?

The combination provides researchers with a defined two-peptide research system containing CJC-1295 No DAC and Ipamorelin.

Research applications can include:

• Peptide structure analysis
• Peptide-receptor interaction research
• Biochemical assay development
• Signaling pathway research
• Stability and degradation studies
• Analytical characterization
• HPLC and LC-MS research
• Structure-function investigations

 

Chemical Information:

• CJC-1295 (No DAC)
  • Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
  • Molecular Weight: 3367.9 g/mol
  • Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg
• Ipamorelin
  • Molecular Formula: C₃₈H₄₉N₉O₅
  • Molecular Weight: 711.86 g/mol
  • Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2

 

FAQ Section

What is CJC-1295 / Ipamorelin?

CJC-1295/Ipamorelin is a research peptide blend containing CJC-1295 without DAC and Ipamorelin, two structurally defined synthetic peptides.

Is this CJC-1295 with or without DAC?

This product is specifically CJC-1295 No DAC / Ipamorelin. CJC-1295 with DAC is a chemically distinct version and should not be presented as the same product.

What is CJC-1295 No DAC?

CJC-1295 No DAC is a synthetic peptide commonly referred to as modified GRF 1-29. Its sequence is listed as Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg.

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂.

What is the molecular weight of CJC-1295 No DAC?

CJC-1295 No DAC is listed at approximately 3367.9 g/mol.

What is the molecular weight of Ipamorelin?

Ipamorelin is listed at approximately 711.86 g/mol.

What is CJC-1295/Ipamorelin used for in research?

The blend can be studied in controlled laboratory research involving peptide structure, receptor interactions, biochemical systems, stability, degradation and analytical characterization.

Is CJC-1295/Ipamorelin the same as CJC-1295 with DAC / Ipamorelin?

No. CJC-1295 No DAC and CJC-1295 with DAC are different peptide forms.